Pacira BioSciences Inc (PCRX)
25.97
-0.84
(-3.13%)
USD |
NASDAQ |
Apr 24, 14:06
Pacira BioSciences Free Cash Flow: 139.49M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 139.49M |
| September 30, 2023 | 130.25M |
| June 30, 2023 | 126.68M |
| March 31, 2023 | 104.65M |
| December 31, 2022 | 115.20M |
| September 30, 2022 | 92.70M |
| June 30, 2022 | 102.44M |
| March 31, 2022 | 103.95M |
| December 31, 2021 | 79.85M |
| September 30, 2021 | 98.06M |
| June 30, 2021 | 82.87M |
| March 31, 2021 | 38.76M |
| December 31, 2020 | 39.23M |
| September 30, 2020 | 28.38M |
| June 30, 2020 | 13.12M |
| March 31, 2020 | 58.36M |
| December 31, 2019 | 60.36M |
| September 30, 2019 | 57.93M |
| June 30, 2019 | 53.34M |
| March 31, 2019 | 43.71M |
| December 31, 2018 | 34.36M |
| September 30, 2018 | 27.23M |
| June 30, 2018 | 6.831M |
| March 31, 2018 | -5.744M |
| December 31, 2017 | -1.481M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.869M |
| June 30, 2017 | 15.14M |
| March 31, 2017 | 15.31M |
| December 31, 2016 | 8.744M |
| September 30, 2016 | 4.188M |
| June 30, 2016 | -10.38M |
| March 31, 2016 | -13.70M |
| December 31, 2015 | -12.27M |
| September 30, 2015 | -14.29M |
| June 30, 2015 | -3.469M |
| March 31, 2015 | 3.38M |
| December 31, 2014 | 3.58M |
| September 30, 2014 | -12.02M |
| June 30, 2014 | -30.59M |
| March 31, 2014 | -47.83M |
| December 31, 2013 | -56.01M |
| September 30, 2013 | -72.22M |
| June 30, 2013 | -75.12M |
| March 31, 2013 | -84.66M |
| December 31, 2012 | -88.39M |
| September 30, 2012 | -72.56M |
| June 30, 2012 | -65.26M |
| March 31, 2012 | -52.79M |
| December 31, 2011 | -37.17M |
| September 30, 2011 | -35.88M |
Free Cash Flow Range, Past 5 Years
13.12M
Minimum
Jun 2020
139.49M
Maximum
Dec 2023
80.30M
Average
82.87M
Median
Jun 2021
Free Cash Flow Benchmarks
| Dynavax Technologies Corp | 96.46M |
| Arbutus Biopharma Corp | -86.94M |
| Chimerix Inc | -69.18M |
| Karyopharm Therapeutics Inc | -92.72M |
| FibroGen Inc | -317.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 47.58M |
| Cash from Investing (Quarterly) | 8.374M |
| Cash from Financing (Quarterly) | -1.779M |
| Free Cash Flow Per Share (Quarterly) | 0.6647 |
| Free Cash Flow to Equity (Quarterly) | 47.93M |
| Free Cash Flow to Firm (Quarterly) | 45.79M |
| Free Cash Flow Yield | 9.81% |